Results 121 to 130 of about 7,885 (162)

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML. [PDF]

Leukemia
Birdwell CE, Fiskus W, Mill CP, Kadia TM, Daver N, DiNardo CD, Sasaki K, Davis JA, Das K, Hou H, Jain A, Malovannaya A, Flores LB, Pourebrahim R, Yuan S, Su X, Ceribelli M, Bhalla KN.   +17 more
europepmc   +1 more source

The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition. [PDF]

Front Cell Dev Biol
Giuntini F, Whitfield JR, Massó-Vallés D, Soucek L.   +3 more
europepmc   +1 more source

Novel regulatory mechanism of choline-O-sulfate and choline catabolism by two BetIs in Alphaproteobacteria. [PDF]

Appl Environ Microbiol
Liu J-R, Li Z-K, Wang M-C, Wang N, Wang Z-Q, Li F-F, Chen Y, Zhang Y-Z, Fu H-H.   +8 more
europepmc   +1 more source

Lipid-modifying pharmacotherapy in diabetes mellitus: A protocol for a systematic review and network meta-analysis of randomised trials. [PDF]

PLoS One
Zhao X, Tang C, Yuan T, Chen J, Shi C, Liu X, Yang R, Zhi Y, Huang W, Zhu C, Chen Y, Wang S.   +11 more
europepmc   +1 more source

Oral antibiotics prescribing patterns and associated diarrhea risk: Public health implications. [PDF]

J Public Health Res
Naumovska Z, Atanasovska E, Djurdjic B, Mladenovska K, Petreska Ivanovska T, Geskovski N, Anceska Netkovska K, Goracinova K, Slaveska Raichki R, Shalabalija D, Mihailova L, Tasevska T, Livrinska Trpeska L, Simonoska Crcarevska M.   +13 more
europepmc   +1 more source

BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cells. [PDF]

J Biol Chem
Nord JA, Makowski SJ, Sidlowski PFW, Bursch KL, Corbett JA, Smith BC.   +5 more
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107. [PDF]

Mol Oncol
Schmitz J, Bartkowiak AL, Rose M, Kolks N, Petzsch P, Solanki V, Stoffel A, Faßbender B, Lepping L, Volkamer J, Köhrer K, Seifert M, Mahmoudi T, Zuiverloon TCM, Niegisch G, Hoffmann MJ.   +15 more
europepmc   +1 more source

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis. [PDF]

Blood Adv
Mascarenhas J, Fogliatto L, Green S, Corvalan I, Traer E, Kirito K, Chuah H, Sakatoku K, Hoeg R, Khawandanah M, Lavie D, Hunter Z, Quinn D, Wang Y, Harb J, Zha J, Malyankar U, Ritchie E.   +17 more
europepmc   +1 more source

Seasonal trends and short-term association between meteorological factors and diarrheal diseases among children under five in Tanzania. [PDF]

PLoS One
Mwing'a GP, Shayo M, Kimu P, Beti M, Wadugu B, Pashet L, Juma MA, Shirima L, Kuchaka D, Kumburu H, Matemba L, Kazyoba PE, Sindato C, Lutambi AM, Muro F, Mmbaga BT, Alifrangis M, Aarestrup FM, Sonda T.   +18 more
europepmc   +1 more source

Endocan as a marker of plasma leakage in dengue patients: a diagnostic study. [PDF]

BMC Infect Dis
Nainggolan L, Anfasa F, Mansjoer A, Dewi BE.   +3 more
europepmc   +1 more source